James Ehrlich, MD, was named chief medical officer of Atherotech (Birmingham, Alabama). Ehrlich has been the medical director of advanced coronary risk assessment and prevention facilities in four U.S. cities and has been primarily involved in the early detection and assessment of coronary, stroke and cancer risk. Atherotech provides testing for undetected and under-treated cardiovascular disease.

Ward Sparacio has been named VP of sales for Confirma (Bellevue, Washington). Previously Sparacio was director of sales for SonoSite. Confirma develops computer-aided diagnostic systems and accessories.

No Comments